Immunosuppressive treatment of protracted hepatitis in small children
Rabenda, C.; Pradota, A.; Rudkowski, Z.
Pediatria Polska 48(3): 351-356
1973
ISSN/ISBN: 0031-3939 PMID: 4693969 Document Number: 63356
Document emailed within 1 workday
Related Documents
Smukalska, E.; Sawiełajc, K.; Szaflarska, M.; Bakowski, J.; Piziewicz, A. 1985: Foreign bodies in the respiratory tract or esophagus in infants and small children as the cause of protracted bronchopulmonary infections Wiadomosci Lekarskie 38(23): 1666-1669Iatsenko, L.A. 1973: Treatment of protracted forms of viral hepatitis with nerobol Terapevticheskii Arkhiv 45(7): 43-47
Olkowski, L. 1970: Development of methods for the surgical treatment of protracted viral hepatitis Wiadomosci Lekarskie 23(7): 559-563
Rudkowski, Z.; Rabenda, C. 1974: Immunosuppressive therapy in chronic hepatitis in children Materia Medica Polona. Polish Journal of Medicine and Pharmacy 6(3): 202-206
Pelikán, V.; Seidlová, V.; Sánová, J.; Komenda, S. 1975: Results of immunosuppressive treatment: Prognosis in chronic active hepatitis Acta Hepato-Gastroenterologica 22(4): 210-214
Maleev, A.; Stoianov, S.; Trenchev, P. 1972: Results of treatment of chronic aggressive hepatitis with immunosuppressive drugs Vutreshni Bolesti 11(3): 117-120
Pariente, A.; Liversain, J.M.; Briaud, M.; Texereau, P. 1997: Prolonged remission of chronic hepatitis C despite corticoid and immunosuppressive treatment Gastroenterologie Clinique et Biologique 21(8-9): 635
Da Silva, L.C.; Mattar, E.; Carrilho, F.J.; Takeda, A.; Sette Júnior, H.; Gayotto, L.C. 1983: Disappearance of hepatitis B surface antigen in chronic type B hepatitis after clinical and laboratorial relapse produced by abrupt withdrawal of immunosuppressive drugs Revista do Instituto de Medicina Tropical de Sao Paulo 25(6): 270-274
Wolko, K.; Kujawa, H.; Mackiewicz, U.; Kiczka, W. 1973: Prognostic value of immunoglobulin determination in protracted forms of viral hepatitis Polski Tygodnik Lekarski 28(48): 1889-1891
Kassas, A.L.; Telegdy, L.; Méhesfalvi, E.; Szilágyi, T.; Mihály, I. 1994: Polyphasic and protracted patterns of hepatitis A infection: a retrospective study Acta Medica Hungarica 50(1-2): 93-98
Thomas, H.C. 1989: Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers: implications for the treatment of chronic HBV carriers Quarterly Journal of Medicine 73(270): 873-874
Miroshnichenko, V.P.; Arshinov, P.S.; Petrov, V.M. 1990: The bile immunoglobulins and electrolytes of patients with acute and protracted courses of viral hepatitis Vrachebnoe Delo 1990(5): 113-116
Routenberg, J.A.; Dienstag, J.L.; Harrison, W.O.; Kilpatrick, M.E.; Hooper, R.R.; Chisari, F.V.; Purcell, R.H.; Fornes, M.F. 1979: Foodborne outbreak of hepatitis A: clinical and laboratory features of acute and protracted illness American Journal of the Medical Sciences 278(2): 123-137
Olkowski, L. 1972: Effect of surgical procedures carried out on the hepatic artery on the course of protracted forms of viral hepatitis Polski Tygodnik Lekarski 27(5): 176-178
Dorofeeva, R.P.; Safonova, L.G. 1970: Blood coagulation system indices in protracted forms of infectious hepatitis with pronounced hemorrhagic syndrome Sovetskaia Meditsina 33(7): 31-35
Jörimann, A. 1971: Immunosuppressive therapy of chronic aggressive hepatitis Acta Hepato-Splenologica 18(3): 192-206
Schimmelpfennig, W.; Wagner, K.; Theuer, D.; Schneider, G. 1973: Immunosuppressive therapy of chronic aggressive hepatitis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(12 Suppl): 177
Maleev, A.; Stojanov, S. 1973: Immunosuppressive therapy of chronic aggressive hepatitis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(20 Suppl): 307-309
Nakai, T.; Kawabe, T.; Satoh, S.; Kurooka, K.; Yasutomi, M. 1996: Immunosuppressive mechanism and immune tolerance of FK 506 in rat small bowel transplantation Transplantation Proceedings 28(2): 1091-1093
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66